Clinical Practice Home-Based tDCS for Major Depressive Disorder: Review Findings and Clinical Impact
The U.S. Food and Drug Administration approved the first at-home brain stimulation device for major depressive disorder in December 2025. Nine months later, a systematic review and meta-analysis in JMIR



